Skip to main content
Log in

News from IHEA

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Associazione Nazionale Medici Cardiologi

References

  1. Burns R, et al. A Cost-Effectiveness Analysis of PSA testing for the secondary prevention of Prostate Cancer in the Republic of Ireland. 10th World Congress of the International Health Economics Association : abstr. N/A, 13 Jul 2014. Available from: URL: https://ihea2014.abstractsubmit.org/presentations/12607/

  2. Pedone MP, et al. Cost-effectiveness analysis of afatinib vs. gefitinib as 1st line treatment for EGFR mutation positive non-small cell lung cancer (NSCLC) in Italy. 10th World Congress of the International Health Economics Association : abstr. N/A, 13 Jul 2014. Available from: URL: https://ihea2014.abstractsubmit.org/presentations/12200/

  3. Favaro A, et al. Cost utility of a telemonitoring service for COPD: preliminary results from the RENEWING HEALTH Project in Italy. 10th World Congress of the International Health Economics Association : abstr. N/A, 13 Jul 2014. Available from: URL: https://ihea2014.abstractsubmit.org/presentations/12107/

  4. Armeni P, et al. Real-world Cost Effectiveness of MitraClip combined with Optimal Medical Therapy versus Optimal Medical Therapy alone: an observational study. 10th World Congress of the International Health Economics Association : abstr. N/A, 13 Jul 2014. Available from: URL: https://ihea2014.abstractsubmit.org/presentations/12702/

  5. Mangen M-JJ, et al. For which high risk adults is a target HBV vaccination campaign cost-effective? 10th World Congress of the International Health Economics Association : abstr. N/A, 13 Jul 2014. Available from: URL: https://ihea2014.abstractsubmit.org/presentations/12750/

  6. Leal J, et al. Cost-effectiveness of prostate cancer screening across jurisdictions in the absence of direct evidence: the case studies of England and the Republic of Ireland. 10th World Congress of the International Health Economics Association : abstr. N/A, 13 Jul 2014. Available from: URL: https://ihea2014.abstractsubmit.org/presentations/12520/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

News from IHEA. PharmacoEcon Outcomes News 711, 24–25 (2014). https://doi.org/10.1007/s40274-014-1533-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1533-4

Navigation